Efficiency of curcuminoids as an adjuvant treatment in plaque type psoriasis

A clinical trial evaluating the efficiency of curcuminoids supplementation as an adjuvant treatment in patients with plaque type psoriasis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20180419003

Enrollment

Registered

2018-04-19

Start date

2018-05-21

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

plaque type psoriasis

Interventions

patients treated with their own standard treatments,patients treated with their own standard treatments concurrent with curcuminoids supplementation

Active Comparator Drug,Experimental Other

Standard treatments,Standard treatments plus curcuminoids

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Plaque type psoriasis (2) Psoriasis Area Severity Index (PASI) score >= 5 or Physicians Global Assessment (PGA) score >= 2

Exclusion criteria

Exclusion criteria: (1) Other types of psoriasis (2) Lactation or pregnancy

Design outcomes

Primary

Measure	Time frame
Psoriasis Area Severity Index (PASI) score Baseline, every month of four-month intervention, withdrawal Physical examination,C-reactive protein Baseline, month 4th of intervention, withdrawal Particle enhanced immunoturbidimetry	—

Secondary

Measure	Time frame
Liver and renal function tests Baseline, month 4th of intervention, withdrawal Automated analyzer	—

Countries

Thailand

Contacts

Public ContactPatarabutr Masaratana

Department of Biochemistry, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

patarabutr.mas@mahidol.ac.th+6624197581

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026